Lunai Bioworks
LNAI
40 hedge funds and large institutions have $7.22M invested in Lunai Bioworks in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
3% more funds holding
Funds holding: 39 → 40 (+1)
8% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 12
0% more ownership
Funds ownership: 0.06% → 0.07% (+0%)
15% less capital invested
Capital invested by funds: $8.54M → $7.22M (-$1.31M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$233K |
| 2 |
Renaissance Technologies
New York
|
+$175K |
| 3 |
JP Morgan Chase
New York
|
+$93.2K |
| 4 |
Morgan Stanley
New York
|
+$85.9K |
| 5 |
HSBC Holdings
London,
United Kingdom
|
+$69K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$150K |
| 2 |
Millennium Management
New York
|
-$129K |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$112K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$65K |
| 5 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$62.9K |
LNAI Hedge Fund Activity: Q4 2020 in Review
40 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q4 2020, worth a combined $7.22M — down 15% from $8.54M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new LNAI positions and 4 closed out — a net gain of 1 holder — while 13 added to existing stakes and 12 trimmed.
The largest buyer was BlackRock, adding an estimated $233K. The largest seller was HRT Financial, exiting entirely with an estimated $150K sold.
- 40 institutional investors held Lunai Bioworks (LNAI) as of Q4 2020, up from 39 in Q3 2020.
- Funds reported $7.22M of Lunai Bioworks stock for Q4 2020, down 15% quarter-over-quarter.
- 5 funds opened new Lunai Bioworks positions in Q4 2020 and 4 closed out, a net change of +1 holder.
- The largest Lunai Bioworks buyer in Q4 2020 was BlackRock, an estimated $233K added.
- The largest Lunai Bioworks seller in Q4 2020 was HRT Financial, an estimated $150K sold.
Based on aggregated 13F filings for Q4 2020.